us1800 103 3691
'TaIL' - An International update on Targeted and Immunotherapy in Lung cancer - 2018...
Meet Team MedGenome @ First national pediatric, neurotransmitter and movement disorders symposium on 9th & 10th June organised by CNS, Pune...
Often referred to as the father of hereditary cancer, Dr. Lynch is a pioneer in the study of cancer and genetics...
MedGenome will be presenting at the Dialogue 2018 conference in Chennai on the 22nd of April. The conference is...
MedGenome is a genomics driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual's genome. Its unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized health care. MedGenome is the market leader for genomic diagnostics in South Asia and a leading provider of genomics research services globally. MedGenome is also a founding member of GenomeAsia 100K, an initiative to sequence 100,000 Genomes in Asia.